Jocil Limited (JOCIL) AI Stock Analysis

Jocil Limited

(NSE:JOCIL)

Select Model

Rating:63Neutral

Action:reiterated

Date:08/27/26

The score is primarily driven by mixed financial performance: a very strong, low-leverage balance sheet offsets uneven profitability and weak recent cash flow trends. Valuation is supportive with a reasonable P/E and the provided dividend yield, while technical signals could not be assessed due to missing indicator data.

Positive Factors

Conservative balance sheetNear-zero leverage gives Jocil financial flexibility and reduces interest and refinancing risk. Stable equity and moderate asset growth provide a durable foundation for maintaining operations and funding industrial-gas capacity through weaker demand cycles.

Negative Factors

Weak recent cash generationRecent weak cash conversion limits the funds available for maintenance, expansion and shareholder distributions, even without meaningful debt. Unless cash generation recovers, reported earnings may not translate into durable financial capacity.

Jocil Limited Business Overview & Revenue Model

Company Description

Jocil Limited, an Indian enterprise, is a manufacturer and supplier of a diverse range of chemical and personal care products. Its offerings include stearic and fatty acids, soap noodles, toilet soaps, refined glycerine, and industrial oxygen. The co...

How the Company Makes Money

Jocil Limited primarily makes money by manufacturing and selling oxygen and other industrial gases to customers under commercial supply arrangements. Key revenue streams are (1) sales of industrial gases (with oxygen typically being the core product)...

Jocil Limited Financial Statement Overview

Summary

Overall fundamentals are mixed. A strong, low-debt balance sheet (high balance sheet score) supports financial stability, but profitability has been unstable with operating losses in FY2024–FY2025 and only a rebound in FY2026. Cash generation is a key weakness, with operating cash flow and free cash flow deteriorating materially in recent years.

Income Statement

56Neutral

Balance Sheet

84Very Positive

Cash Flow

45Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	10.27B	10.44B	8.66B	7.53B	9.19B	7.54B
Gross Profit	1.24B	1.33B	1.11B	1.54B	1.69B	893.41M
EBITDA	149.96M	170.92M	72.44M	90.79M	200.89M	164.50M
Net Income	82.55M	83.00M	10.20M	17.27M	99.95M	71.27M
Balance Sheet
Total Assets	0	3.01B	2.88B	2.79B	2.54B	2.57B
Cash, Cash Equivalents and Short-Term Investments	508.58M	508.58M	506.36M	548.50M	363.49M	35.49M
Total Debt	0	0	0	56.45M	16.01M	43.45M
Total Liabilities	-2.13B	872.42M	815.89M	681.21M	472.12M	535.88M
Stockholders Equity	2.13B	2.13B	2.06B	2.11B	2.06B	2.04B
Cash Flow
Free Cash Flow	-432.45M	4.69M	26.50M	135.40M	369.59M	-191.82M
Operating Cash Flow	-419.18M	24.75M	114.27M	169.93M	379.00M	-169.93M
Investing Cash Flow	156.56M	-132.88M	-43.74M	13.25M	-291.00M	138.50M
Financing Cash Flow	47.66M	-4.44M	-69.78M	14.93M	-56.56M	-5.29M

Jocil Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:JOCIL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:JOCIL	63Neutral	INR 904.55M	14.53	―	2.59%	14.37%	593.14%
IN:PODDARMENT	60Neutral	INR 2.79B	18.11	―	1.53%	3.55%	-21.35%
IN:AARTISURF	56Neutral	INR 3.96B	21.00	―	0.22%	25.22%	20.38%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:KANORICHEM	45Neutral	INR 7.38B	12.76	―	―	-22.78%	―
IN:MANORG	38Underperform	INR 3.81B	18.59	―	―	17.28%	-10.19%

* General Sector Average

Performance Comparison

IN:JOCIL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:AARTISURF	Aarti Surfactants Ltd.	467.55	-4.13	-0.88%
IN:JDORGOCHEM	Jaysynth Orgochem Ltd	14.02	-2.81	-16.69%
IN:KANORICHEM	Kanoria Chemicals & Industries Ltd	168.90	91.12	117.15%
IN:MANORG	Mangalam Organics Ltd	445.00	-66.40	-12.98%
IN:PODDARMENT	Poddar Pigments Limited	262.80	-8.53	-3.14%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 27, 2026

Jocil Limited AI Stock Analysis